XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Identifiable Intangible Assets (Tables) | 9 Months Ended
--- | ---
Oct. 02, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Finite-Lived Intangible Assets |
The following summarizes the components of Identifiable intangible assets:
|  | October 2, 2022 |  | December 31, 2021
(MILLIONS) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Identifiable Intangible Assets, less Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Developed technology rights |  | $ | 72,818 |  |  | $ | (55,309) |  |  | $ | 17,509 |  |  | $ | 73,346 |  |  | $ | (53,732) |  |  | $ | 19,614 |
Brands |  | 922 |  |  | (832) |  |  | 90 |  |  | 922 |  |  | (807) |  |  | 115 |
Licensing agreements and other |  | 2,296 |  |  | (1,373) |  |  | 923 |  |  | 2,284 |  |  | (1,299) |  |  | 985 |
|  | 76,036 |  |  | (57,514) |  |  | 18,522 |  |  | 76,552 |  |  | (55,838) |  |  | 20,714 |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Brands |  | 827 |  |  |  |  | 827 |  |  | 827 |  |  |  |  | 827 |
IPR&D(a) |  | 7,829 |  |  |  |  | 7,829 |  |  | 3,092 |  |  |  |  | 3,092 |
Licensing agreements and other(a) |  | 972 |  |  |  |  | 972 |  |  | 513 |  |  |  |  | 513 |
|  | 9,629 |  |  |  |  | 9,629 |  |  | 4,432 |  |  |  |  | 4,432 |
Identifiable intangible assets(a), (b) |  | $ | 85,665 |  |  | $ | (57,514) |  |  | $ | 28,151 |  |  | $ | 80,984 |  |  | $ | (55,838) |  |  | $ | 25,146 |
(a)The increase in the gross carrying amounts mainly reflect the impact of the acquisition of Arena (see Note 2A), and for IPR&D, is partially offset by an impairment (see Note 4). (b)The increase is primarily due to the acquisition of Arena, partially offset by amortization expense.
Schedule of Indefinite Lived Intangible Assets |
The following summarizes the components of Identifiable intangible assets:
|  | October 2, 2022 |  | December 31, 2021
(MILLIONS) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Identifiable Intangible Assets, less Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization |  | Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Developed technology rights |  | $ | 72,818 |  |  | $ | (55,309) |  |  | $ | 17,509 |  |  | $ | 73,346 |  |  | $ | (53,732) |  |  | $ | 19,614 |
Brands |  | 922 |  |  | (832) |  |  | 90 |  |  | 922 |  |  | (807) |  |  | 115 |
Licensing agreements and other |  | 2,296 |  |  | (1,373) |  |  | 923 |  |  | 2,284 |  |  | (1,299) |  |  | 985 |
|  | 76,036 |  |  | (57,514) |  |  | 18,522 |  |  | 76,552 |  |  | (55,838) |  |  | 20,714 |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Brands |  | 827 |  |  |  |  | 827 |  |  | 827 |  |  |  |  | 827 |
IPR&D(a) |  | 7,829 |  |  |  |  | 7,829 |  |  | 3,092 |  |  |  |  | 3,092 |
Licensing agreements and other(a) |  | 972 |  |  |  |  | 972 |  |  | 513 |  |  |  |  | 513 |
|  | 9,629 |  |  |  |  | 9,629 |  |  | 4,432 |  |  |  |  | 4,432 |
Identifiable intangible assets(a), (b) |  | $ | 85,665 |  |  | $ | (57,514) |  |  | $ | 28,151 |  |  | $ | 80,984 |  |  | $ | (55,838) |  |  | $ | 25,146 |
(a)The increase in the gross carrying amounts mainly reflect the impact of the acquisition of Arena (see Note 2A), and for IPR&D, is partially offset by an impairment (see Note 4). (b)The increase is primarily due to the acquisition of Arena, partially offset by amortization expense.
Schedule of Goodwill |
The following summarizes the changes in the carrying amount of Goodwill:
(MILLIONS) |  |  |  |  |  |  |  |  |  | Total(a)
Balance, January 1, 2022 |  |  |  |  |  |  |  |  |  | $ | 49,208 |
Additions(b) |  |  |  |  |  |  |  |  |  | 1,029 |
Other(c) |  |  |  |  |  |  |  |  |  | (797) |
Balance, October 2, 2022 |  |  |  |  |  |  |  |  |  | $ | 49,441 |
(a)All goodwill is assigned within the Biopharma reportable segment. As a result of the organizational changes to the commercial structure within the Biopharma operating segment effective in the third quarter of 2022 (see Note 1A), our goodwill is required to be reallocated amongst impacted reporting units. The allocation of goodwill is a complex process that requires, among other things, that we determine the fair value of each reporting unit under our old and new organizational structure and the portions being transferred. Therefore, we have not yet completed the allocation, but it will be completed in the current year. (b)Additions relate to our acquisition of Arena. See Note 2A. (c)Other represents the impact of foreign exchange.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 55 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b),(d) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration